AKR1C1 promotes non-small cell lung cancer proliferation via crosstalk between HIF-1α and metabolic reprogramming

Non-small cell lung cancer (NSCLC) ranks first among cancer death worldwide. Despite efficacy and safety priority, targeted therapy only benefits ∼30% patients, leading to the unchanged survival rates for whole NSCLC patients. Metabolic reprogramming occurs to offer energy and intermediates for fuel...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Lin-Lin Chang, Pei-Hua Lu, Wei Yang, Yan Hu, Lin Zheng, Qiong Zhao, Neng-Ming Lin, Wen-Zhou Zhang
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Elsevier 2022-06-01
Schriftenreihe:	Translational Oncology
Schlagworte:	HIF-1α AKR1C1 Metabolic reprogramming Proliferation
Online-Zugang:	http://www.sciencedirect.com/science/article/pii/S193652332200081X
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!